Sidney S. Loxley, M.D.; Revocation of Registration, 30172-30173 [06-4839]
Download as PDF
30172
Federal Register / Vol. 71, No. 101 / Thursday, May 25, 2006 / Notices
Gazaly Trading, supra, 69 FR 22561;
Shani Distributors, supra, 68 FR 62326.
Finally, it is noted that Respondent
seeks to distribute
phenylpropanolamine. Accordingly, the
Deputy Administrator finds factor five
relevant to H & R’s request to distribute
phenylpropanolamine and the apparent
lack of safety associated with the use of
that product. DEA has previously
determined that an applicant’s request
to distribute phenylpropanolamine
constitutes a ground under factor five
for denial of an application for
registration. See, J & S Distributors,
supra, 69 FR 62089; Gazaly Trading,
supra, 69 FR 22561; William E. ‘‘Bill’’
Smith d/b/a B & B Wholesale, supra, 69
FR 22559; Shani Distributors, supra, 68
FR 62324.
Based on the foregoing, the Deputy
Administrator concludes that granting
Respondent’s pending application
would be inconsistent with the public
interest.
Accordingly, the Deputy
Administrator of the Drug Enforcement
Administration, pursuant to the
authority vested in her by 21 U.S.C. 823
and CFR 0.100(b) and 0.104, hereby
orders that the pending application for
a DEA Certificate of Registration,
previously submitted by H & R
Corporation, be, and it hereby is,
denied. This order is effective June 26,
2006.
Dated: May 5, 2006.
Michele M. Leonhart,
Deputy Administrator.
[FR Doc. 06–4838 Filed 5–24–06; 8:45am]
BILLING CODE 4410–09–M
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
cchase on PROD1PC60 with NOTICES
Sidney S. Loxley, M.D.; Revocation of
Registration
On January 25, 2005, the Deputy
Administrator of the Drug Enforcement
Administration (DEA) issued an Order
to Show Cause and Immediate
Suspension of Registration to Sidney S.
Loxley, M.D. (Dr. Loxley) of
Chesapeake, Virginia. Dr. Loxley was
notified of an opportunity to show cause
as to why DEA should not revoke his
DEA Certificate of Registration,
AL6366428, as a practitioner, and deny
any pending applications for renewal or
modification of that registration
pursuant to 21 U.S.C. 823(f) and
824(a)(4) on the basis that his continued
registration would be inconsistent with
the public interest. Dr. Loxley was
further notified that pursuant to 21
U.S.C. 824(d), his DEA registration was
VerDate Aug<31>2005
16:42 May 24, 2006
Jkt 208001
being immediately suspended as an
imminent danger to the public health
and safety.
The Order to Show Cause and
Immediate Suspension of Registration
alleged that Dr. Loxley had been the
subject of two prior disciplinary
proceedings before the Virginia Board of
Medicine (Virginia Board). In June 1993,
his medical license had been suspended
for 16 months as a result of his abusing
the patient-doctor relationship by
engaging in a sexual relationship with a
minor and for a related misdemeanor
conviction of contributing to the
delinquency of a minor. His state
license was reinstated in October 1994
but in a subsequent disciplinary
proceeding occurring in October 2003, it
was placed on probation for a period of
not less than three years. At that time
the Virginia Board found, along with
several controlled substance
recordkeeping violations reflecting gross
incompetence, that Dr. Loxley had
improperly prescribed controlled
substances to his wife, who was not his
patient and was chemically dependent.
As a condition of his probation, Dr.
Loxley was directed to complete a Board
approved course in the proper
prescribing of controlled substances.
The Order to Show Cause and
Immediate Suspension of Registration
alleged, in sum, that Dr. Loxley had
been issuing prescriptions for large
amounts of controlled substances to
individuals without the physical
examinations, testing or evaluations
which are consistent with a legitimate
doctor-patient relationship. These
prescriptions were not issued for
legitimate medical purposes or in the
usual course of professional treatment,
thus violating 21 CFR 1306.04 and 21
U.S.C. 841(a). It was further alleged that
between September 2003 and May 2004,
on ten separate occasions Dr. Loxley
issued prescriptions under these
circumstances to a DEA Special Agent
and a confidential source who had been
posing undercover as patients. Profiles
obtained from area pharmacies covering
the period between August and
December 2004 indicated he was
continuously prescribing large
quantities of controlled narcotic
substances, primarily oxycodone and
hydrocodone, in 120 tablet quantities to
patients without apparent legitimate
medical reasons and supplier records
shows that Dr. Loxley was the largest
orderer of Demerol (meperidine), among
all orthopedic surgeons in the Virginia
Tidewater area.
Finally, it was alleged that four
patients of Dr. Loxley had died while
under his care as a result of possible
excessive prescribing, that he prescribed
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
controlled substances while under the
influence of alcohol and had recently
been convicted of driving while
intoxicated in state court.
According to the investigative file, the
Order to Show Cause and Immediate
Suspension of Registration was
personally served on Dr. Loxley by a
DEA Diversion Investigator on January
27, 2005. More than thirty days have
passed since service of the Order to
Show Cause and Immediate Suspension
of Registration and DEA has not
received a request for hearing or any
other reply from Dr. Loxley or anyone
purporting to represent him in this
matter.
Therefore, the Deputy Administrator
of DEA, finding that (1) thirty days
having passed since the delivery of the
Order to Show Cause and Immediate
Suspension of Registration to Dr.
Loxley, and (2) not request for hearing
having been received, concludes that Dr.
Loxley is deemed to have waived his
hearing right. See David W. Linder, 67
FR 12579 (2002). After considering
material from the investigative file in
this matter, the Deputy Administrator
now enters her final order without a
hearing pursuant 21 CFR 1301.43(d) and
(e) and 1301.46.
The Deputy Administrator finds the
Dr. Loxley is currently registered with
DEA as a practitioner under DEA
Certificate of Registration AL 6366424.
According to information in the
investigative file, on January 20, 2005,
and indictment was unsealed by order
of the United States District court,
Eastern District of Virginia (Norfolk),
charging Dr. Loxley with 91 felony
counts relating to the unlawful
distribution and dispensing of
controlled substances without a
legitimate medical purpose under 21
U.S.C. 841(a)(1) and (b)(1)C). The
indictment includes four counts alleging
that a death had resulted from Dr.
Loxley’s unlawful distribution and
dispensing. On the date the indictment
was unsealed, Dr. Loxley was arrested
and he remains in custody pending trial
in the matter of USA v. Sidney Loxley
(Case No. 2:04–cr–00236–WDK–JEB–
ALL).
On February 25, 2005, the Virginia
Board notified Dr. Loxley that an
informal conference had been scheduled
to address allegations of multiple
violations of state laws and regulations
governing the practice of medicine and
surgery and an allegation that he was
unfit for the performance of his
professional obligations and duties and
unable to practice medicine with
reasonable skill and safety. In response,
Dr. Loxley advised the Virginia Board
that he was currently unable to address
E:\FR\FM\25MYN1.SGM
25MYN1
cchase on PROD1PC60 with NOTICES
Federal Register / Vol. 71, No. 101 / Thursday, May 25, 2006 / Notices
the allegations because of the pending
criminal charges and was willing to
surrender his license, pending
resolution of that matter.
On May 20, 2005, after the
investigative file was received by the
Deputy Administrator, Dr. Loxley
entered into a Consent Agreement with
the Virginia Board in which he agreed
to surrender his state medical license,
pending the outcome of the criminal
case. In the event he is acquitted of all
charges, his license will be reinstated.
However, if he is convicted of any
misdemeanor or felony counts, it is to
remain surrendered until further order
of the Virginia Board. Upon entry of the
Consent Agreement, Dr. Loxley’s
medical license was recorded as being
surrendered and no longer current.
There is no evidence before the
Deputy Administrator that the Consent
Agreement has been modified, lifted or
stayed or that Dr. Loxley’s Virginia
medical license has been reinstated or
renewed.
Pursuant to 21 U.S.C. 824(a)(3), the
Deputy Administrator may revoke a
DEA Certificate of Registration if she
finds the registrant has had state license
revoked and is no longer authorized to
dispense controlled substances in the
jurisdiction of registration.
Alternatively, revocation is authorized if
the registrant has committed such acts
as would render his registration
contrary to the public interest, as
determined by factors listed in 21 U.S.C.
823(f). See Thomas B. Pelkowski,
D.D.S., 57 FR 28538 (1992).
Despite Dr. Loxley’s egregious and
unlawful activities and the public
interest factors that are implemented by
such unprofessional and criminal
conduct, his lack of state authorization
to handle controlled substances is
dispositive of this matter.
DEA does not have statutory authority
under the Controlled Substances Act to
issue or maintain a registration if the
applicant or registrant is without state
authority to handle controlled
substances in the state in which he
conducts business. See 21 U.S.C.
802(21), 823(f) and 824(a)(3). This
prerequisite has been consistently
upheld. See Rory Patrick Doyle, M.D.,
69 FR 11655 (2004); Dominick A. Ricci,
M.D., 58 FR 51104 (1993); Bobby Watts,
M.D., 53 FR 11919 (1988).
Here, it is clear Dr. Loxley
surrendered his medical license and it
is reasonable to infer that he is currently
not authorized to handle controlled
substances in Virginia and is therefore
not entitled to a DEA registration in that
state. As a result of the finding that Dr.
Loxley lacks any state authorization to
handle controlled substances, the
VerDate Aug<31>2005
18:38 May 24, 2006
Jkt 208001
Deputy Administrator concludes it is
unnecessary to address further whether
his DEA registration should be revoked
based upon the public interest grounds
asserted in the Order to Show Cause and
Immediate Suspension of Registration.
See Gilbert C. Aragon, Jr., D.O., 69 FR
58536 (2004); Samuel Silas Jackson,
D.D.S., 67 FR 65145 (2002); NathanielAikens-Afful, M.D., 62 FR 16871 (1997);
Sam F. Moore. D.V.M., 58 FR 14428
(1993).
Accordingly, the Deputy
Administrator of the Drug Enforcement
Administration, pursuant to the
authority vested in her by 21 U.S.C. 823
and 824 and 28 CFR 0.100(b) and 0.104,
hereby orders that DEA Certificate of
Registration, AL6366428, issued to
Sidney S. Loxley, M.D., be, and it
hereby is, revoked. The Deputy
Administrator further orders that any
pending applications for renewal or
modification of such registration be, and
they hereby are, denied. This order is
effective June 26, 2006.
Dated: July 6, 2005.
Michele M. Leonhart,
Deputy Administrator.
[FR Doc. 06–4839 Filed 5–24–06; 8:45 am]
BILLING CODE 4410–09–M
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Worth S. Wilkinson, M.D.; Revocation
of Registration
On March 1, 2005, the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration (DEA), issued an Order
to Show Cause to Worth S. Wilkinson,
M.D. (Dr. Wilkinson) of Shreveport,
Louisiana, notifying him of an
opportunity to show cause as to why
DEA should not revoke his DEA
Certification of Registration BW2217974
under 21 U.S.C. 824(a)(3) and deny any
pending applications for renewal or
modification of that registration
pursuant to 21 U.S.C. 823(f). As a basis
for revocation, the Order to Show Cause
alleged that Dr. Wilkinson is not
currently authorized to practice
medicine or handle controlled
substances in Louisiana, his state of
registration and practice. The Order to
Show Cause also notified Dr. Wilkinson
that should no request for a hearing be
filed within 30 days, his hearing right
would be deemed waived.
The Order to Show Cause was sent by
certified mail to Dr. Wilkinson at his
registered address at 729 Wichita Street,
Shreveport, Louisiana 71101 and to his
residence at 700 Delaware, Shreveport,
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
30173
Louisiana 71101. According to the
return receipt the Order to Show Cause
sent to his home was received by Dr.
Wilkinson on March 9, 2005. DEA has
not received a request for hearing or any
other reply from Dr. Wilkinson or
anyone purporting to represent him in
this matter.
Therefore, the Deputy Administrator
of DEA, finding that thirty days having
passed since the delivery of the Order
to Show Cause to the registrant and no
request for hearing having been
received, concludes that Dr. Wilkinson
is deemed to have waived his hearing
right. See Thomas J. Mulhearn, III, M.D.,
70 FR 24625 (2005); James E. Thomas,
M.D., 70 FR 3564 (2005); Steven A.
Barnes, M.D., 69 FR 51474 (2004); David
W. Linder, 67 FR 12579 (2002).
After considering material from the
investigative file in this matter, the
Deputy Administrator now enters her
final order without a hearing pursuant
to 21 CFR 1301.43(d) and (e) and
1301.46.
The Deputy Administrator finds Dr.
Wilkinson currently possesses DEA
Certificate of Registration BW2217974,
as a practitioner authorized to handle
controlled substances in Schedules IV–
V. The Deputy Administrator further
finds that on October 29, 2004, the
Louisiana State Board of Medical
Examiners (Louisiana Board) issued an
Opinion and Ruling suspending Dr.
Wilkinson’s license to practice medicine
in Louisiana.
That suspension was based upon the
Louisiana Board’s conclusion that Dr.
Wilkinson was in need of further testing
and evaluation for alcohol abuse and his
apparent physical and mental inability
to practice medicine with reasonable
skill and safety to his patients.
The investigative file contains no
evidence that the Louisiana Board’s
Opinion and Ruling has been stayed,
modified or terminated or that Dr.
Wilkinson’s medical license has been
reinstated. Therefore, the Deputy
Administrator finds Dr. Wilkinson is not
currently authorized to practice
medicine in the State of Louisiana. As
a result, it is reasonable to infer he is
also without authorization to handle
controlled substances in that state.
DEA does not have statutory authority
under the Controlled Substances Act to
issue or maintain a registration if the
applicant or registrant is without state
authority to handle controlled
substances in the state in which he
conducts business. See 21 U.S.C.
802(21), 823(f) and 824(a)(3). This
prerequisite has been consistently
upheld. See Stephen J. Graham, M.D.,
69 FR 11661 (2004); Dominick A. Ricci,
M.D., 58 FR 51104 (1993); Bobby Watts,
E:\FR\FM\25MYN1.SGM
25MYN1
Agencies
[Federal Register Volume 71, Number 101 (Thursday, May 25, 2006)]
[Notices]
[Pages 30172-30173]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-4839]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Sidney S. Loxley, M.D.; Revocation of Registration
On January 25, 2005, the Deputy Administrator of the Drug
Enforcement Administration (DEA) issued an Order to Show Cause and
Immediate Suspension of Registration to Sidney S. Loxley, M.D. (Dr.
Loxley) of Chesapeake, Virginia. Dr. Loxley was notified of an
opportunity to show cause as to why DEA should not revoke his DEA
Certificate of Registration, AL6366428, as a practitioner, and deny any
pending applications for renewal or modification of that registration
pursuant to 21 U.S.C. 823(f) and 824(a)(4) on the basis that his
continued registration would be inconsistent with the public interest.
Dr. Loxley was further notified that pursuant to 21 U.S.C. 824(d), his
DEA registration was being immediately suspended as an imminent danger
to the public health and safety.
The Order to Show Cause and Immediate Suspension of Registration
alleged that Dr. Loxley had been the subject of two prior disciplinary
proceedings before the Virginia Board of Medicine (Virginia Board). In
June 1993, his medical license had been suspended for 16 months as a
result of his abusing the patient-doctor relationship by engaging in a
sexual relationship with a minor and for a related misdemeanor
conviction of contributing to the delinquency of a minor. His state
license was reinstated in October 1994 but in a subsequent disciplinary
proceeding occurring in October 2003, it was placed on probation for a
period of not less than three years. At that time the Virginia Board
found, along with several controlled substance recordkeeping violations
reflecting gross incompetence, that Dr. Loxley had improperly
prescribed controlled substances to his wife, who was not his patient
and was chemically dependent. As a condition of his probation, Dr.
Loxley was directed to complete a Board approved course in the proper
prescribing of controlled substances.
The Order to Show Cause and Immediate Suspension of Registration
alleged, in sum, that Dr. Loxley had been issuing prescriptions for
large amounts of controlled substances to individuals without the
physical examinations, testing or evaluations which are consistent with
a legitimate doctor-patient relationship. These prescriptions were not
issued for legitimate medical purposes or in the usual course of
professional treatment, thus violating 21 CFR 1306.04 and 21 U.S.C.
841(a). It was further alleged that between September 2003 and May
2004, on ten separate occasions Dr. Loxley issued prescriptions under
these circumstances to a DEA Special Agent and a confidential source
who had been posing undercover as patients. Profiles obtained from area
pharmacies covering the period between August and December 2004
indicated he was continuously prescribing large quantities of
controlled narcotic substances, primarily oxycodone and hydrocodone, in
120 tablet quantities to patients without apparent legitimate medical
reasons and supplier records shows that Dr. Loxley was the largest
orderer of Demerol (meperidine), among all orthopedic surgeons in the
Virginia Tidewater area.
Finally, it was alleged that four patients of Dr. Loxley had died
while under his care as a result of possible excessive prescribing,
that he prescribed controlled substances while under the influence of
alcohol and had recently been convicted of driving while intoxicated in
state court.
According to the investigative file, the Order to Show Cause and
Immediate Suspension of Registration was personally served on Dr.
Loxley by a DEA Diversion Investigator on January 27, 2005. More than
thirty days have passed since service of the Order to Show Cause and
Immediate Suspension of Registration and DEA has not received a request
for hearing or any other reply from Dr. Loxley or anyone purporting to
represent him in this matter.
Therefore, the Deputy Administrator of DEA, finding that (1) thirty
days having passed since the delivery of the Order to Show Cause and
Immediate Suspension of Registration to Dr. Loxley, and (2) not request
for hearing having been received, concludes that Dr. Loxley is deemed
to have waived his hearing right. See David W. Linder, 67 FR 12579
(2002). After considering material from the investigative file in this
matter, the Deputy Administrator now enters her final order without a
hearing pursuant 21 CFR 1301.43(d) and (e) and 1301.46.
The Deputy Administrator finds the Dr. Loxley is currently
registered with DEA as a practitioner under DEA Certificate of
Registration AL 6366424. According to information in the investigative
file, on January 20, 2005, and indictment was unsealed by order of the
United States District court, Eastern District of Virginia (Norfolk),
charging Dr. Loxley with 91 felony counts relating to the unlawful
distribution and dispensing of controlled substances without a
legitimate medical purpose under 21 U.S.C. 841(a)(1) and (b)(1)C). The
indictment includes four counts alleging that a death had resulted from
Dr. Loxley's unlawful distribution and dispensing. On the date the
indictment was unsealed, Dr. Loxley was arrested and he remains in
custody pending trial in the matter of USA v. Sidney Loxley (Case No.
2:04-cr-00236-WDK-JEB-ALL).
On February 25, 2005, the Virginia Board notified Dr. Loxley that
an informal conference had been scheduled to address allegations of
multiple violations of state laws and regulations governing the
practice of medicine and surgery and an allegation that he was unfit
for the performance of his professional obligations and duties and
unable to practice medicine with reasonable skill and safety. In
response, Dr. Loxley advised the Virginia Board that he was currently
unable to address
[[Page 30173]]
the allegations because of the pending criminal charges and was willing
to surrender his license, pending resolution of that matter.
On May 20, 2005, after the investigative file was received by the
Deputy Administrator, Dr. Loxley entered into a Consent Agreement with
the Virginia Board in which he agreed to surrender his state medical
license, pending the outcome of the criminal case. In the event he is
acquitted of all charges, his license will be reinstated. However, if
he is convicted of any misdemeanor or felony counts, it is to remain
surrendered until further order of the Virginia Board. Upon entry of
the Consent Agreement, Dr. Loxley's medical license was recorded as
being surrendered and no longer current.
There is no evidence before the Deputy Administrator that the
Consent Agreement has been modified, lifted or stayed or that Dr.
Loxley's Virginia medical license has been reinstated or renewed.
Pursuant to 21 U.S.C. 824(a)(3), the Deputy Administrator may
revoke a DEA Certificate of Registration if she finds the registrant
has had state license revoked and is no longer authorized to dispense
controlled substances in the jurisdiction of registration.
Alternatively, revocation is authorized if the registrant has committed
such acts as would render his registration contrary to the public
interest, as determined by factors listed in 21 U.S.C. 823(f). See
Thomas B. Pelkowski, D.D.S., 57 FR 28538 (1992).
Despite Dr. Loxley's egregious and unlawful activities and the
public interest factors that are implemented by such unprofessional and
criminal conduct, his lack of state authorization to handle controlled
substances is dispositive of this matter.
DEA does not have statutory authority under the Controlled
Substances Act to issue or maintain a registration if the applicant or
registrant is without state authority to handle controlled substances
in the state in which he conducts business. See 21 U.S.C. 802(21),
823(f) and 824(a)(3). This prerequisite has been consistently upheld.
See Rory Patrick Doyle, M.D., 69 FR 11655 (2004); Dominick A. Ricci,
M.D., 58 FR 51104 (1993); Bobby Watts, M.D., 53 FR 11919 (1988).
Here, it is clear Dr. Loxley surrendered his medical license and it
is reasonable to infer that he is currently not authorized to handle
controlled substances in Virginia and is therefore not entitled to a
DEA registration in that state. As a result of the finding that Dr.
Loxley lacks any state authorization to handle controlled substances,
the Deputy Administrator concludes it is unnecessary to address further
whether his DEA registration should be revoked based upon the public
interest grounds asserted in the Order to Show Cause and Immediate
Suspension of Registration. See Gilbert C. Aragon, Jr., D.O., 69 FR
58536 (2004); Samuel Silas Jackson, D.D.S., 67 FR 65145 (2002);
Nathaniel-Aikens-Afful, M.D., 62 FR 16871 (1997); Sam F. Moore. D.V.M.,
58 FR 14428 (1993).
Accordingly, the Deputy Administrator of the Drug Enforcement
Administration, pursuant to the authority vested in her by 21 U.S.C.
823 and 824 and 28 CFR 0.100(b) and 0.104, hereby orders that DEA
Certificate of Registration, AL6366428, issued to Sidney S. Loxley,
M.D., be, and it hereby is, revoked. The Deputy Administrator further
orders that any pending applications for renewal or modification of
such registration be, and they hereby are, denied. This order is
effective June 26, 2006.
Dated: July 6, 2005.
Michele M. Leonhart,
Deputy Administrator.
[FR Doc. 06-4839 Filed 5-24-06; 8:45 am]
BILLING CODE 4410-09-M